Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-081741
Filing Date
2025-06-04
Accepted
2025-06-04 17:08:28
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4951
  Complete submission text file 0000950170-25-081741.txt   7052
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Issuer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809
Business Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809 (302) 992-8882
GKCC, LLC (Reporting) CIK: 0001977769 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 251024023

Mailing Address C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501 BOSTON MA 02210
Business Address
Chudnovsky Yekaterina (Reporting) CIK: 0001979324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 251024024